Last reviewed · How we verify
Carcinoma of cervix
Approved treatments
- Avastin · Washington University School of Medicine
- Bevacizumab · Roche
Bevacizumab binds VEGF and prevents interaction with endothelial cell receptors Flt-1 and KDR. - Avastin · Roche
Bevacizumab works by binding to VEGF-A, preventing it from promoting the growth of new blood vessels that feed tumors.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Carcinoma of cervix patent landscape — cliff calendar, originator estates, attackable patents
- Carcinoma of cervix treatment landscape brief
- Carcinoma of cervix treatment updates RSS
Frequently asked questions about Carcinoma of cervix
What drugs treat Carcinoma of cervix?
Tracked treatments include Avastin, Bevacizumab.
What is the treatment for Carcinoma of cervix?
Standard treatment for Carcinoma of cervix includes Avastin, Bevacizumab. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Carcinoma of cervix patent cliff · Carcinoma of cervix CI report
- Treatment: Avastin · Washington University School of Medicine
- Treatment: Bevacizumab · Roche
- Treatment: Avastin · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing